During the past decade, St. Marien-Hospital Hamm - Klinik Knappenstrasse conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Marien-Hospital Hamm - Klinik Knappenstrasse" #1 sponsor was "German CLL Study Group" with 4 trials, followed by "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 2 trials sponsored, "Technische Universität Dresden" with 2 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored and "CTI BioPharma" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Marien-Hospital Hamm - Klinik Knappenstrasse" #1 collaborator was "German CLL Study Group" with 1 trials as a collaborator, "Heart Center Leipzig - University Hospital" with 1 trials as a collaborator, "Masaryk University" with 1 trials as a collaborator, "Novartis" with 1 trials as a collaborator and "Universitätsklinikum Dresden, Nationales Centrum für Tumorerkrankungen Dresden (NCT/UCC)" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "St. Marien-Hospital Hamm - Klinik Knappenstrasse" are "Chronic Lymphocytic Leukemia" (4 trials), "Leukemia" (2 trials), "Lymphoma" (2 trials), "Acute Myeloid Leukemia" (1 trials) and "Chronic Heart Failure" (1 trials). Many other conditions were trialed in "St. Marien-Hospital Hamm - Klinik Knappenstrasse" in a lesser frequency.

Most popular intervention types in "St. Marien-Hospital Hamm - Klinik Knappenstrasse" are "Drug" (12 trials), "Biological" (4 trials), "Procedure" (4 trials), "Radiation" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (4 trials), "radiation therapy" (3 trials), "Fludarabine" (2 trials), "cytarabine" (2 trials) and "doxorubicin hydrochloride" (2 trials). Other intervention names were less common.

The vast majority of trials in "St. Marien-Hospital Hamm - Klinik Knappenstrasse" are 14 trials for "All" genders.

Currently, there are NaN active trials in "St. Marien-Hospital Hamm - Klinik Knappenstrasse". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in St. Marien-Hospital Hamm - Klinik Knappenstrasse, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in St. Marien-Hospital Hamm - Klinik Knappenstrasse, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".